Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
06/08/2026 13:01
BRIEF-Edgewise Therapeutics Q2 Operating Income USD -61.943 Million Aug 06 (Reuters) - Edgewise Therapeutics Q2 operating expenses USD 61.943 million.
- Q2 net income USD -57.327 million
- Q2 basic EPS USD -0.53
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending